
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
Zhi Li, Hua Zhang, Xixi Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Zhi Li, Hua Zhang, Xixi Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Cuproptosis: mechanisms and links with cancers
Jiaming Xie, Yannan Yang, Yibo Gao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 417
Jiaming Xie, Yannan Yang, Yibo Gao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 417
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 74
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 74
Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment
Mingyue Xie, Bo Cheng, Shuang Yu, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 173-173
Open Access | Times Cited: 39
Mingyue Xie, Bo Cheng, Shuang Yu, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 173-173
Open Access | Times Cited: 39
Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma
Duguang Li, Zhaoqi Shi, Xiaolong Liu, et al.
Hepatology International (2023) Vol. 17, Iss. 1, pp. 112-130
Closed Access | Times Cited: 23
Duguang Li, Zhaoqi Shi, Xiaolong Liu, et al.
Hepatology International (2023) Vol. 17, Iss. 1, pp. 112-130
Closed Access | Times Cited: 23
A novel signature combing cuproptosis- and ferroptosis-related genes in sepsis-induced cardiomyopathy
Juanjuan Song, Kairui Ren, Dexin Zhang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 23
Juanjuan Song, Kairui Ren, Dexin Zhang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 23
Mechanisms of cuproptosis and its relevance to distinct diseases
Qiao-mei Lou, Feifan Lai, Jingwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 981-1006
Closed Access | Times Cited: 12
Qiao-mei Lou, Feifan Lai, Jingwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 981-1006
Closed Access | Times Cited: 12
Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer
Mingxing Zhang, Yani Su, Pengfei Wen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Mingxing Zhang, Yani Su, Pengfei Wen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
In what area of biology has a “new” type of cell death been discovered?
Xixi Wang, Junyi Lin, Zhi Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188955-188955
Closed Access | Times Cited: 18
Xixi Wang, Junyi Lin, Zhi Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188955-188955
Closed Access | Times Cited: 18
Cuproptosis-related genes predict prognosis and trastuzumab therapeutic response in HER2-positive breast cancer
Rui Sha, Xinrui Dong, Shanshan Yan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Rui Sha, Xinrui Dong, Shanshan Yan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer
Jixian Li, Wentao Zhang, Xiaoqing Ma, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Jixian Li, Wentao Zhang, Xiaoqing Ma, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
Jiahui Liang, Xin Wang, Jing Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Jiahui Liang, Xin Wang, Jing Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Cuproptosis-related gene CDKN2A as a molecular target for IPF diagnosis and therapeutics
Baowen Xu, Kaiyong Yang, Xin Han, et al.
Inflammation Research (2023) Vol. 72, Iss. 6, pp. 1147-1160
Closed Access | Times Cited: 12
Baowen Xu, Kaiyong Yang, Xin Han, et al.
Inflammation Research (2023) Vol. 72, Iss. 6, pp. 1147-1160
Closed Access | Times Cited: 12
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
Xixi Wang, Junyi Lin, Zhe Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Xixi Wang, Junyi Lin, Zhe Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer
Chao Li, Yongqiang Xiao, Heran Cao, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 1, pp. 99-110
Closed Access | Times Cited: 11
Chao Li, Yongqiang Xiao, Heran Cao, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 1, pp. 99-110
Closed Access | Times Cited: 11
The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
Bingye Shi, Wei Zhang, Tao Wang, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Bingye Shi, Wei Zhang, Tao Wang, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)
Leyu Ai, Na Yi, Chunhan Qiu, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 4
Leyu Ai, Na Yi, Chunhan Qiu, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 4
Identification of cuproptosis hub genes contributing to the immune microenvironment in ulcerative colitis using bioinformatic analysis and experimental verification
Cejun Yang, Wendi Wang, Sang Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Cejun Yang, Wendi Wang, Sang Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
SLC7A11, a disulfidptosis-related gene, correlates with multi-omics prognostic analysis in hepatocellular carcinoma
Shizhe Li, Xiaotong Wang, Jie Xiao, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Shizhe Li, Xiaotong Wang, Jie Xiao, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Yun Chen, Jun Liu, Ying Zhu
Cancer Reports (2025) Vol. 8, Iss. 5
Open Access
Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancer
Chunjie Sun, Hanyun Zhang, Ye Li, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27356-e27356
Open Access | Times Cited: 3
Chunjie Sun, Hanyun Zhang, Ye Li, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27356-e27356
Open Access | Times Cited: 3
Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer
Dongni Zhang, Wenping Lü, Zhili Zhuo, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Dongni Zhang, Wenping Lü, Zhili Zhuo, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma
Wei Yuan, Junhao Xiao, Jiansong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Wei Yuan, Junhao Xiao, Jiansong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Cuproptosis-associated ncRNAs predict breast cancer subtypes
Qing Xia, Jinze Shen, Qurui Wang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0299138-e0299138
Open Access | Times Cited: 2
Qing Xia, Jinze Shen, Qurui Wang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0299138-e0299138
Open Access | Times Cited: 2